Invida markets a wide range of branded pharmaceutical, biotechnology, medical device, and other healthcare products, including consumer health, with more than 70 brands across 13 markets in Asia Pacific.

Building on our strengths in Dermatology, Primary Care, Consumer Health and Specialty Care, Invida has experienced an impressive compound annual revenue growth of 31 percent from 2005 to 2010.

Our leading brands include:

Dermatology

•  Aesthetic

Kinerase^® - anti-aging
Gly Derm^® - holistic skin care range

•  Therapeutic

Atopiclair^TM – eczema
Sebclair^TM – seborrheic dermatitis
Papulex^TM – acne-prone skin  

Primary Care

Distaclor/Ceclor^® - first line antibiotic for a wide range of infections
Vancocin^® - second or third line antibiotic for severe infections

Consumer Health

Dermatix^® - scar management
OmegaGen^® - cholesterol management
Breacol^® - cough and cold
Actal^® - antacid
Kamillosan^® - anti-inflammatory mouth spray

Specialty Care

•  Neurology

Mestinon^® - myasthenia gravis

•  Oncology Supportive Care

Sancuso™- chemotherapy induced nausea and vomiting
Xclair^TM – radiation dermatitis